Metabolon logo

Metabolomics and the Exposome

Metabolites are the Dynamic Measure of Wellness and Exposures

Less than 20% of chronic disease risk is driven by genetics1; the rest arises from environmental, lifestyle, and therapeutic factors. These forces shape biology through small molecules that reflect real-time physiology. Metabolomics captures this dynamic signature of health and disease, revealing how exposures translate to biology and outcomes. Metabolon’s platform transforms these insights into precision medicine and population health impact.

Accelerate Your Exposome Research Today

Request a quote, get detailed information on sample types, or learn how metabolomics can accelerate your exposome research.

mayo clinic
mayo clinic
mayo clinic
mayo clinic
mayo clinic
mayo clinic

Your Research is Incomplete Without the Metabolome

Metabolomics is functional readout of biology—revealing how genes, environment, and interventions converge. Without it, critical connections between exposure, mechanism, and outcome remain unseen.

metabolomics academic 1
$

Discovery

Metabolomics Reveals What Remains Hidden from Genetics: the Molecular Fingerprint of Exposures

Genetics lays the groundwork for understanding inherited traits, but it doesn’t capture how the environment actively shapes biology. Metabolomics fills this gap by measuring the real-time biochemical imprints of exposures—diet, pollution, microbiome interactions, and more. These molecular fingerprints provide critical insight into how external factors contribute to disease mechanisms, often before symptoms arise. This power of discovery makes metabolomics essential for uncovering unknown pathways, novel biomarkers, and unrecognized drivers of health and disease.  

$

Precision Medicine

Current Health Status is the Readout of your Metabolism; Metabolomics is the Solution that Empowers Personalized Health Management in Real Time

By translating dynamic biochemical data into actionable insight, metabolomics enables truly individualized care. It reveals how a person’s body may or is responding to their environment, diet, medications, and underlying health in real time. This allows clinicians to predict therapeutic response, optimize treatment plans, and monitor outcomes for interventions ranging from lifestyle changes to biologics. With metabolomics, precision medicine becomes proactive, adaptive, and uniquely patient-centered.

metabolomics academic 2
metabolomics academic 1
$

Population Health

Metabolomics is the Dynamic Health Measure of your Genes and Environment

At scale, metabolomics helps map the biological consequences of shared exposures—such as air pollution, diet, or urban stress—across communities and cohorts. It enables early detection of metabolic vulnerabilities, stratifies disease risk, and highlights disparities linked to social determinants of health. These insights inform targeted prevention strategies and population-level interventions. Metabolomics thus equips public health leaders with a molecular toolkit to promote equity and resilience across diverse populations.

icon quotes

“Integrated metabolomics is a really powerful tool to understand this entire spectrum of health.”

Jessica Lasky-Su, PhD
Remarks during the webinar “Using the Metabolome in Multiomic Context to Inform Biological Aging and Precision Medicine” (Metabolon, [June 19th, 2025])

Featured Exposome Resources

Learn more about how metabolomics can help you define the exposome.

$

On Demand Webinar: Metabolic Variation Reflects Dietary Intake in a Multi-ethnic Asian Population

$

On Demand Webinar: Accelerated Metabolic Aging In Chronic Obstructive Pulmonary Disease

$

Case Study: Identifying UPF Biomarkers and Thier Impact On Health

Exposome Publications and Citations

Metabolon has contributed extensively to publications ranging from basic research to clinical trials.

Genome-wide characterization of circulating metabolic biomarkers

Karjalainen, M.K., et al.

Combining genome-wide association analysis with global metabolomics, this study characterized thousands of circulating biomarkers that define a reference map of genetically regulated metabolism. The results establish a biochemical bridge between genetic variation and disease risk—providing the baseline upon which environmental and lifestyle exposures act.

Metabolome-wide association identifies ferredoxin-1 (FDX1) as a determinant of cholesterol metabolism and cardiovascular risk in Asian populations.

Sadhu, N., et al.

Through a metabolome-wide association approach, this study identified FDX1 as a key regulator of cholesterol metabolism and mitochondrial redox balance. As a novel biochemical target and determinant of cholesterol-related cardiovascular risk, FDX1 defines a mechanistic backbone through which genetic and environmental factors converge to influence cardiometabolic health.

Microbiome-metabolome dynamics associated with impaired glucose control and responses to lifestyle changes.

Wu, H., et al.

Using integrated microbiome and metabolomics analyses, this study revealed how diet and exercise remodel the gut microbiome and circulating metabolites in individuals with impaired glucose control. By distinguishing responders from non-responders to lifestyle intervention, it pinpointed pathways of glucose homeostasis and demonstrated how metabolomics links environmental exposures to personalized treatment response.

Associations of APOE variants with sphingomyelin and cholesterol metabolites across the life-course in diverse populations.

Lee, S., et al.

Leveraging Metabolon data across multi-ethnic cohorts, this study demonstrated how APOE genotypes shape lipid metabolism throughout the lifespan. These findings show how metabolomics adds biochemical precision to population-based genetic risk assessment.

Metabolic aging as an increased risk for chronic obstructive pulmonary disease.

Guo, C.J., et al.

This study applied global metabolomics across a large cohort to define a biochemical signature of “metabolic aging” that predicts COPD independent of chronological age or genetics. By quantifying how lifelong physiological and environmental exposures reshape systemic metabolism, it illustrates how metabolomics captures the molecular fingerprints of cumulative health risk across populations.

Exposome FAQs

Metabolon strives to ensure your metabolomics study is successful and offers key insights into your scientific questions. We support you at every step from study design to data delivery.

K
L
What are the Exposome and Exposomics?

The exposome encompasses all environmental influences—from diet and pollution to stress and lifestyle—that shape health across the lifespan. Exposomics is the science of measuring and interpreting those exposures to understand how the environment interacts with our biology to drive health and disease.

K
L
Why is Metabolomics Indispensable for Exposomic Research?

Metabolomics turns the exposome into measurable biology—capturing both exposures and their effects in a single snapshot. While genomics tells us what could happen, metabolomics shows what is happening, offering the clearest view of how the environment influences health.

K
L
How Does Metabolomics Help with My Exposomics Research?

Metabolon has the most expansive library of named metabolites linked to environmental exposures—ranging from industrial pollutants to microbiome-derived intermediates. This breadth allows researchers to detect both the presence of exposures and their downstream biological effects within a single analysis.

The Leading Untargeted Metabolomics Solution

Gain access to unrivaled data insights from our untargeted metabolomics service, leveraging the largest level 1 annotated library of metabolites for commercial use. Explore over 70 biochemical pathways and detect up to 5,400 metabolites in a single biological sample.

GET STARTED

Talk with an expert

Request a quote, get detailed information on sample types, or learn how metabolomics can accelerate your research. Find our contact details are here.

Find us on:

Talk with a Metabolomics expert